Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy

The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in th...

Full description

Saved in:
Bibliographic Details
Main Authors: Özge Yanık, Figen Batıoğlu, Nilüfer Yalçındağ, Sibel Demirel, Emin Özmert
Format: Article
Language:English
Published: Galenos Publishing House 2022-04-01
Series:Türk Oftalmoloji Dergisi
Subjects:
Online Access: http://www.oftalmoloji.org/archives/archive-detail/article-preview/atypical-chronic-central-serous-chorioretinopathy-/51891
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849405899482857472
author Özge Yanık
Figen Batıoğlu
Nilüfer Yalçındağ
Sibel Demirel
Emin Özmert
author_facet Özge Yanık
Figen Batıoğlu
Nilüfer Yalçındağ
Sibel Demirel
Emin Özmert
author_sort Özge Yanık
collection DOAJ
description The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in the left. She described a similar decline in vision in her right eye 8 years ago. At that time, she had exudative retinal detachment and was treated with systemic immunosuppressive therapy for a presumed diagnosis of Vogt-Koyanagi-Harada disease. Despite resolution of the exudative retinal detachment, macular scarring developed. Eight years later, she developed inferior exudative retinal detachment in the left eye. A diagnosis of atypical CSCR was made with the help of multimodal imaging and her left eye was successfully treated with eplerenone and half-fluence photodynamic therapy (hf-PDT). In conclusion, early diagnosis and treatment of atypical CSCR may prevent subretinal fibrosis formation and permanent vision loss. Hf-PDT and eplerenone are successful treatment options for atypical CSCR.
format Article
id doaj-art-4e98adae85234725a37f97e84980e861
institution Kabale University
issn 1300-0659
2147-2661
language English
publishDate 2022-04-01
publisher Galenos Publishing House
record_format Article
series Türk Oftalmoloji Dergisi
spelling doaj-art-4e98adae85234725a37f97e84980e8612025-08-20T03:36:34ZengGalenos Publishing HouseTürk Oftalmoloji Dergisi1300-06592147-26612022-04-0152214715210.4274/tjo.galenos.2022.9321313049054Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic TherapyÖzge Yanık0Figen Batıoğlu1Nilüfer Yalçındağ2Sibel Demirel3Emin Özmert4 Ankara Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye Ankara Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye Ankara Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye Ankara Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye Ankara Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in the left. She described a similar decline in vision in her right eye 8 years ago. At that time, she had exudative retinal detachment and was treated with systemic immunosuppressive therapy for a presumed diagnosis of Vogt-Koyanagi-Harada disease. Despite resolution of the exudative retinal detachment, macular scarring developed. Eight years later, she developed inferior exudative retinal detachment in the left eye. A diagnosis of atypical CSCR was made with the help of multimodal imaging and her left eye was successfully treated with eplerenone and half-fluence photodynamic therapy (hf-PDT). In conclusion, early diagnosis and treatment of atypical CSCR may prevent subretinal fibrosis formation and permanent vision loss. Hf-PDT and eplerenone are successful treatment options for atypical CSCR. http://www.oftalmoloji.org/archives/archive-detail/article-preview/atypical-chronic-central-serous-chorioretinopathy-/51891 atypical central serous chorioretinopathyindocyanine green angiographyphotodynamic therapyeplerenone
spellingShingle Özge Yanık
Figen Batıoğlu
Nilüfer Yalçındağ
Sibel Demirel
Emin Özmert
Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
Türk Oftalmoloji Dergisi
atypical central serous chorioretinopathy
indocyanine green angiography
photodynamic therapy
eplerenone
title Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_full Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_fullStr Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_full_unstemmed Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_short Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_sort atypical chronic central serous chorioretinopathy mimicking vogt koyanagi harada disease full therapeutic response to half fluence photodynamic therapy
topic atypical central serous chorioretinopathy
indocyanine green angiography
photodynamic therapy
eplerenone
url http://www.oftalmoloji.org/archives/archive-detail/article-preview/atypical-chronic-central-serous-chorioretinopathy-/51891
work_keys_str_mv AT ozgeyanık atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy
AT figenbatıoglu atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy
AT niluferyalcındag atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy
AT sibeldemirel atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy
AT eminozmert atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy